Leah Binder

Leah Binder

Leah is the President & CEO of The Leapfrog Group, a national organization based in Washington, DC, representing employer purchasers of health care calling for improvements in the safety of the nation’s hospitals. She is an influential voice for major change in healthcare.  For each of the past three years she was named on Modern Healthcare’s list of the 100 Most Influential People in Healthcare, and one of 20 people making healthcare better in Health Leaders Magazine.  Leah sits on numerous national boards and committees, including the Institute of Medicine Collaboration on Patient Engagement, the National Priorities Partnership Board, and the Advisory Board of the Institute for Interactive Patient Care. She is a frequent speaker on hospital safety and quality, and the importance of payment reform and transparency.

Before joining Leapfrog in the spring of 2008, Leah spent 8 years as Vice President at an award-winning rural hospital network in Farmington, Maine, Franklin Community Health Network.  Prior to that, she was a senior policy advisor for the Office of Mayor Rudolph Giuliani in New York City. She started her career at the National League for Nursing, where she handled policy and communications for over 6 years.

Leah has a B.A. from Brandeis University and two masters from the University of Pennsylvania, one from the Annenberg School of Communication and the other from the Fels Institute of Government.

Sir Iain Chalmers

Iain Chalmers practiced as a clinician for seven years in the UK and the Gaza Strip, before becoming a full time health services researcher. Between 1978 and 1992 he was founding director of the National Perinatal Epidemiology Unit. Between 1992 and 2002, he was founding director of the UK Cochrane Centre, which convened the meeting at which the Cochrane Collaboration was inaugurated. Since 2003, he has coordinated the James Lind Initiative to promote public and professional acknowledgement of the need to address uncertainties about the effects of treatments. He is coordinating editor of The James Lind Library and Testing Treatments Interactive. He was knighted in 2000 for services to health care.

Tim Ferriss

Timothy has been listed as one of Fast Company’s “Most Innovative Business People of 2007,” Forbes Magazine’s “Names You Need to Know in 2011,” and is the 7th “most powerful” personality on Newsweek’s Digital 100 Power Index for 2012. He is an angel investor/advisor (Twitter, Evernote, Uber, Facebook, StumbleUpon, DonorsChoose.org, and others) and author of the #1 New York Times, Wall Street Journal, and BusinessWeek bestseller, The 4-Hour Workweek, which has been sold into more than 35 languages. He’s also author of the #1 New York Times bestseller, The 4-Hour Body.

Newsweek calls Tim “the world’s best guinea pig,” which he takes a compliment.  When not acting as a human guinea pig, Tim enjoys speaking to organizations ranging from Nike to the Harvard School of Public Health.

Tim received his degree in East Asian studies from Princeton University.

James Lambright

James Lambright

As the Senior Vice President for Corporate Development at Sempra Energy (Fortune 500 Company), Jim directs Sempra Energy’s investments, strategic partnerships, and acquisitions.  The Sempra Energy companies’ 17,500 employees serve more than 31 million consumers.

Previously as the Chief Investment Officer of the U.S. Treasury Department’s $700 billion Troubled Asset Relief Program (TARP) and Chief Executive Officer of the U.S. Export-Import Bank, Jim successfully led organizations through the challenges lying at the intersection of finance, government, global markets, and a breadth of industries.

During the financial crisis of 2008-2009, Jim built the team, policies, and programs to execute and manage the Treasury Department’s TARP investments.  Under Secretaries Hank Paulson and Tim Geithner, he was responsible for over 600 investments in the country’s largest banks, insurers, and auto manufacturers, with the goals of optimizing returns and preventing the collapse of the financial system.

Earlier, Jim oversaw a $60 billion credit portfolio of project and export finance transactions as head of the U.S. Export-Import Bank, the independent government corporation responsible for financing U.S. exports to over 150 countries.  During his tenure, Jim transformed Ex-Im Bank into a self-financing institution operating without taxpayer funds.

Jim began his career at Donaldson, Lufkin & Jenrette (later Credit Suisse) after receiving degrees with distinction from Stanford University and with honors from Harvard Law School.  He has been an instructor at Stanford University, a member of the U.S. President’s Export Council, a Crown Fellow of the Aspen Institute, a principal in the first five U.S.-China Strategic Economic Dialogues, and a frequent delegate to the Australian-American Leadership Dialogue.

Mitch Lazar, M.D., Ph.D.

Mitch Lazar, M.D., Ph.D.

Mitch is the Sylvan H. Eisman Professor of Medicine and Genetics, the Chief of the Division of Endocrinology, Diabetes, and Metabolism, and the Director of the Institute for Diabetes, Obesity, and Metabolism at the University of Pennsylvania. His current research focus is on the epigenomic regulation of gene expression and metabolism. Mitch discovered the heme receptor Rev-erbα and the epigenomic mechanisms by which it represses gene transcription to control circadian and metabolic physiology. He has also made seminal findings related to the role of PPARγ in obesity and diabetes, including the discovery of the hormone called resistin. Mitch has been elected to the American Society for Clinical Investigation and the Association of American Physicians, the Institute of Medicine of the National Academy of Sciences, and to the American Academy of Arts and Sciences. He has received numerous awards, including two National Institutes of Health Merit Awards.

Mitch received his B.S. in Chemistry from the Massachusetts Institute of Technology, his Ph.D. in Neuroscience and his M.D. from Stanford University. He trained in internal medicine at Brigham and Women’s Hospital in Boston and in endocrinology at the Massachusetts General Hospital.

Marty Makary, M.D.

Marty Makary, M.D., M.P.H.

Marty Makary, M.D., M.P.H. is a FOX News and CNN commentator and author of the best-selling book Unaccountable: What Hospitals Won’t Tell You and How Transparency Can Revolutionize Healthcare.

In addition to his national advocacy on patient empowerment, Marty is a busy pancreas surgeon at Johns Hopkins Hospital.  He has been a leader in the field of pancreatic diseases and is the director of the Johns Hopkins Pancreas Islet Transplant Center.  Marty serves on the faculty with a joint appointment as an Associate Professor of Health Policy at the Johns Hopkins School of Public Health. He led the effort of the World Health Organization (WHO) to measure hospital complications and was the first to publish studies on the use of a checklist in surgery.  He later worked closely with Dr. Atul Gawande to develop the official WHO checklist. Dr. Gawande credits the co-development of the surgical checklist to Marty in his best-selling book, The Checklist Manifesto.

Marty’s research has appeared in the New England Journal of Medicine and numerous other medical journals.  He is the recipient of research grants from the Department of Health and Human Services Agency for Healthcare Research and Quality and has written extensively on the subject of patient empowerment in healthcare. He serves in leadership roles at the American College of Surgeons and is the author of a textbook of surgery used in many medical schools around the world.  In 2007, Marty was named the Mark Ravitch Chair of Gastrointestinal Surgery. After three years in this role, he was appointed to his current role as Director of Surgery Quality and Safety at Johns Hopkins.

Marty holds degrees from Bucknell University, Thomas Jefferson University and Harvard University.  He completed his surgical training at Georgetown University and sub-specialty training at Johns Hopkins University.

Jason Pressman

Jason Pressman

Jason is a Managing Director of Shasta Ventures, an early stage venture firm with over $700 million dollars under management.  At Shasta, Jason invests in early stage technology companies in the software, Internet and mobile spaces.  Jason has extensive experience with building businesses as an executive, advisor and investor.  Prior to joining Shasta Ventures in 2005, Jason served as Vice President of Strategy, Business Development at Walmart.com, a venture-backed company. In that role, Jason helped build the business into one of the leading commerce sites on the Web. Before Walmart.com, Jason worked as an investment banker at Alex-Brown, advising start-ups on financing and mergers and acquisitions.  Jason earned his M.B.A. from the Stanford Graduate School of Business. He also holds a B.S. in finance with honors from the University of Maryland.

Gretchen Rubin

Gretchen Rubin

Gretchen Rubin is the author of the book Happier at Home, as well as the blockbuster #1 New York Times and international bestseller,The Happiness Project. On her popular blog, The Happiness Project,  she reports on her daily adventures in the pursuit of happiness.  The Happiness Project is more than a book and a blog, it’s a movement.  Happiness Project groups have sprung up around the world; hundreds of book groups have discussed the book; and rights for more than 30 foreign editions have been sold. The Happiness Project was even an answer on the game-show Jeopardy!

Gretchen is an enthusiastic proponent of using technology to engage with readers about ideas, and she has a wide, active following on Twitter, Facebook, her monthly newsletter, and her daily email of happiness quotations.

A graduate of Yale and Yale Law School, where she was editor-in-chief of the Yale Law Journal, Gretchen started her career in law, and she was clerking for Justice Sandra Day O’Connor when she realized she really wanted to be a writer.


  • Donate or get involved Connect and talk to us